| Sandra Isnasious, MD | |
|
3215 N Sepulveda Blvd, Manhattan Beach, CA 90266-2453 | |
| (424) 295-0540 | |
| Not Available |
| Full Name | Sandra Isnasious |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 3215 N Sepulveda Blvd, Manhattan Beach, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174908685 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A146762 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pih Health Hospital-whittier | Whittier, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Torrance Health Association Inc | 1355302134 | 249 |
| Intercommunity Emergency Medical Group | 7911892534 | 38 |
News Archive
New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery - to the same extent as chemotherapy but without the side-effects of chemotherapy.
Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).
The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.
A new edition of "AACN Scope and Standards for Acute Care Nurse Practitioner Practice" is now available from the American Association of Critical-Care Nurses in downloadable PDF, mobile-friendly and print versions.
HIV-positive people worldwide are at an increased risk of the H1N1 flu strain, the World Health Organization said on Saturday in guidelines for health workers published on its Web site, Reuters India reports.
› Verified 4 days ago
| Entity Name | Providence Facey Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710031588 PECOS PAC ID: 3173436276 Enrollment ID: O20031105000822 |
News Archive
New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery - to the same extent as chemotherapy but without the side-effects of chemotherapy.
Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).
The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.
A new edition of "AACN Scope and Standards for Acute Care Nurse Practitioner Practice" is now available from the American Association of Critical-Care Nurses in downloadable PDF, mobile-friendly and print versions.
HIV-positive people worldwide are at an increased risk of the H1N1 flu strain, the World Health Organization said on Saturday in guidelines for health workers published on its Web site, Reuters India reports.
› Verified 4 days ago
| Entity Name | Intercommunity Emergency Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871535286 PECOS PAC ID: 7911892534 Enrollment ID: O20040708000780 |
News Archive
New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery - to the same extent as chemotherapy but without the side-effects of chemotherapy.
Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).
The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.
A new edition of "AACN Scope and Standards for Acute Care Nurse Practitioner Practice" is now available from the American Association of Critical-Care Nurses in downloadable PDF, mobile-friendly and print versions.
HIV-positive people worldwide are at an increased risk of the H1N1 flu strain, the World Health Organization said on Saturday in guidelines for health workers published on its Web site, Reuters India reports.
› Verified 4 days ago
| Entity Name | South Coast Emergency Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831294594 PECOS PAC ID: 8628049608 Enrollment ID: O20040803001437 |
News Archive
New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery - to the same extent as chemotherapy but without the side-effects of chemotherapy.
Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).
The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.
A new edition of "AACN Scope and Standards for Acute Care Nurse Practitioner Practice" is now available from the American Association of Critical-Care Nurses in downloadable PDF, mobile-friendly and print versions.
HIV-positive people worldwide are at an increased risk of the H1N1 flu strain, the World Health Organization said on Saturday in guidelines for health workers published on its Web site, Reuters India reports.
› Verified 4 days ago
| Entity Name | Torrance Health Association Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083903124 PECOS PAC ID: 1355302134 Enrollment ID: O20110819000276 |
News Archive
New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery - to the same extent as chemotherapy but without the side-effects of chemotherapy.
Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).
The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.
A new edition of "AACN Scope and Standards for Acute Care Nurse Practitioner Practice" is now available from the American Association of Critical-Care Nurses in downloadable PDF, mobile-friendly and print versions.
HIV-positive people worldwide are at an increased risk of the H1N1 flu strain, the World Health Organization said on Saturday in guidelines for health workers published on its Web site, Reuters India reports.
› Verified 4 days ago
| Entity Name | Exer Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588901532 PECOS PAC ID: 9032359534 Enrollment ID: O20130705000153 |
News Archive
New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery - to the same extent as chemotherapy but without the side-effects of chemotherapy.
Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).
The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.
A new edition of "AACN Scope and Standards for Acute Care Nurse Practitioner Practice" is now available from the American Association of Critical-Care Nurses in downloadable PDF, mobile-friendly and print versions.
HIV-positive people worldwide are at an increased risk of the H1N1 flu strain, the World Health Organization said on Saturday in guidelines for health workers published on its Web site, Reuters India reports.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sandra Isnasious, MD 3215 N Sepulveda Blvd, Manhattan Beach, CA 90266-2453 Ph: (424) 295-0540 | Sandra Isnasious, MD 3215 N Sepulveda Blvd, Manhattan Beach, CA 90266-2453 Ph: (424) 295-0540 |
News Archive
New, long-term results from a clinical trial presented at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery - to the same extent as chemotherapy but without the side-effects of chemotherapy.
Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH).
The National Institutes of Health announced today a second phase of the Rare Diseases Clinical Research Network (RDCRN) including funds for 19 research consortia.
A new edition of "AACN Scope and Standards for Acute Care Nurse Practitioner Practice" is now available from the American Association of Critical-Care Nurses in downloadable PDF, mobile-friendly and print versions.
HIV-positive people worldwide are at an increased risk of the H1N1 flu strain, the World Health Organization said on Saturday in guidelines for health workers published on its Web site, Reuters India reports.
› Verified 4 days ago
Gregor Mciver, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 836 14th St, Manhattan Beach, CA 90266 Phone: 310-346-9422 | |
Peter James Bloomfield, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 229 16th St, Manhattan Beach, CA 90266 Phone: 310-218-7002 | |
Dr. Albert Tuong-quang Nguyen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1467 6th St, Manhattan Beach, CA 90266 Phone: 909-528-7026 | |
David Sung Kwon, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 111 N Sepulveda Blvd, #210, Manhattan Beach, CA 90266 Phone: 310-379-2134 | |
Jose L Cervantes, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 N Sepulveda Blvd, #543, Manhattan Beach, CA 90266 Phone: 424-217-3227 | |
Andrea W Wu, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 111 N Sepulveda Blvd, Suite 210, Manhattan Beach, CA 90266 Phone: 310-379-2134 |